Pharmista Technologies ApS — Credit Rating and Financial Key Figures
CVR number: 44617072
Ole Maaløes Vej 3, 2200 København N
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | -1 599.56 |
| EBIT | -1 599.56 |
| Other financial income | 21.87 |
| Other financial expenses | - 123.80 |
| Pre-tax profit | -1 701.49 |
| Net earnings | -1 701.49 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Non-curr. owed by group member comp. | 616.22 |
| Long term receivables total | 616.22 |
| Inventories total | |
| Current other receivables | 3.50 |
| Short term receivables total | 3.50 |
| Cash and bank deposits | 1 814.80 |
| Cash and cash equivalents | 1 814.80 |
| Balance sheet total (assets) | 2 434.53 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Profit of the financial year | -1 701.49 |
| Shareholders equity total | -1 661.49 |
| Capital loans | 4 096.02 |
| Non-current liabilities total | 4 096.02 |
| Current liabilities total | |
| Balance sheet total (liabilities) | 2 434.53 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.